Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
7th grade Good
|
|
New words:
Accel, acquire, acquired, acumen, Additionally, affirmatively, age, Ai, Akron, Alberta, Alexander, ALZA, Ambit, Amgen, Anderson, Anesiva, appraisal, Arno, ASC, Asian, aspect, assessment, assure, attainment, average, background, bankrupt, basic, Baxter, Bayer, Baylor, Beijing, BioCheck, BioHealth, biopharmaceutical, Blutt, bring, Burrill, Byte, Calgary, cancelled, cancer, Capman, carrying, CASI, caution, Cayman, Centocor, chairmen, chapter, Chi, Chime, China, Chinese, Christopher, classified, CNS, column, combination, combining, commencement, competition, computing, concluded, conduct, conducted, conjunction, conserve, consistency, consisting, Consonance, consortia, COO, copy, counted, coupled, create, criminal, Crown, deep, delete, delisted, demonstrated, diagnosing, difficulty, digit, diluted, dilution, diminution, discretion, distributed, distribution, divided, Divinity, DNA, Donahue, Dongliang, Doxil, Eden, effort, electronically, enabled, entirety, entity, entrepreneurial, equipment, ETP, EVOMELA, exact, exclusive, exempted, existing, expanded, expatriate, expended, expense, expertise, extension, extensive, extent, extra, facilitate, facility, failure, Federated, Fei, fiber, focused, focusing, Food, forfeited, forged, fourth, Franklin, front, Fudan, fulfilling, full, fully, Gem, Georgia, Glaxo, GlaxoSmithKline, GP, grossly, guide, historical, Ho, honor, Huang, Huazhen, Hugo, Human, Hydrochloride, IA, Ibritumomab, IDG, ii, impact, implement, import, inability, income, indirect, Injection, injured, innovative, insight, instrumentation, Interactive, interfere, inventor, invoice, involuntary, IP, Irrevocable, issuer, iv, Jianguang, Jingran, jointly, JSR, judgment, Kindstar, Kleiner, KPMG, lab, lack, language, large, larger, largest, Larry, launch, laundry, leader, learning, Li, Lin, Liposome, literacy, LLP, Longevity, LP, lump, machine, main, MARQIBO, master, matching, Mayo, MedImmune, Melphalan, merchant, method, MGI, milestone, missing, Mitchell, mixture, modify, molecule, monthly, Moon, nasdaq, necessarily, negligent, net, NFCR, NMPA, nonprofit, nuclear, obtained, occupation, occurred, occurrence, Ohio, opinion, Opportunity, order, original, originally, Orion, Ortho, outbreak, Pacific, Panacea, pandemic, Pennsylvania, People, percent, perpetual, person, Pharma, pharmacy, pipeline, pool, position, preclinical, predict, presence, preventing, primarily, pro, profit, proposed, protect, protection, provision, publicly, purpose, put, Qi, qualified, qualify, quality, Quan, quorum, Rajesh, ranging, rata, ratably, ratification, read, recognize, recognized, recommended, reduce, reducing, reform, region, relationship, relocation, remuneration, rent, rental, Republic, resume, retroactive, revised, revision, revoked, Rhodora, risk, RMB, Roche, Rockville, royalty, safety, Salisbury, Sandoz, scale, seasoned, sector, sequencing, settled, shareholder, shell, Shong, Shrotriya, similar, Similarly, Sing, single, small, smaller, Snow, space, Sparkle, Spectrum, spouse, St, stage, standing, Stanford, Starvax, stipulation, strategic, sublease, submit, submitted, substantial, substantially, sufficient, suggested, Suite, Sulfate, sum, SuperGen, supply, support, supported, supporting, surviving, Symbol, Tactiva, Taxotere, terminology, testing, therapy, thirty, Tianjin, tiered, title, Tiuxetan, transaction, transformative, Translational, TriArm, Trust, tuition, Tularik, twelve, UCLA, unable, unaffiliated, unanticipated, uncertainty, underlying, undue, Unimicro, uniquely, UNLV, upfront, USD, Utah, valuable, Velcade, vi, Vincristine, virtue, vision, Vivo, volatility, waived, waiver, Wealth, Wei, weighted, Weihao, Wellcome, Wharton, Windtree, worldwide, WSH, Wu, Wuxi, Xeloda, Xie, Xu, XW, Yale, Yang, yuan, ZEVALIN, Zhang, Zhou, Ziopharm, Zukiwski
Removed:
academic, Acorn, active, advisor, Agriculture, Alternative, America, American, area, Askew, attorney, authorized, Bain, balance, behalf, biodiversity, biological, Brook, Byrne, campaign, Carella, Cecchi, Cie, Clinton, complied, compounded, consultant, consulting, Cornell, Council, counsel, covered, Dane, delegate, delinquent, Department, depend, designated, dispose, donald, economic, Editor, Emory, employed, employee, England, entremed, Environmental, exceeded, family, gain, genetic, Geneva, Georgetown, Gilfillan, Glickman, graduated, Hill, holder, Institute, jennie, Jersey, keynote, Kilpatrick, knight, Laboratory, Lawrence, Lecturer, legal, London, Merck, merged, Microbiology, multiplying, mutual, Nath, nominee, North, OECD, Olstein, peter, Porter, practicing, prescribed, randall, rate, realized, recently, representative, Resource, retirement, Roseland, Saglio, Sarasin, Secretary, SIM, South, Stewart, Stockton, subtracting, Switzerland, telephone, thereto, thereunto, unauthorized, undersigned, unvested, Virginia, West, Wunder, York
Filing tables
Filing exhibits
CASI similar filings
Filing view
External links
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, Wei-Wu He, certify that:
| 1. | I have reviewed this annual report on Form 10-K/A of CASI Pharmaceuticals, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2021
| By: | /s/Wei-Wu He | |
| Wei-Wu He | ||
| Chief Executive Officer |